Thomas Donner

2.1k total citations · 1 hit paper
29 papers, 1.4k citations indexed

About

Thomas Donner is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Thomas Donner has authored 29 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Genetics and 6 papers in Surgery. Recurrent topics in Thomas Donner's work include Diabetes Management and Research (13 papers), Diabetes and associated disorders (9 papers) and Diabetes Treatment and Management (6 papers). Thomas Donner is often cited by papers focused on Diabetes Management and Research (13 papers), Diabetes and associated disorders (9 papers) and Diabetes Treatment and Management (6 papers). Thomas Donner collaborates with scholars based in United States, Spain and Canada. Thomas Donner's co-authors include Abdel Rahim A. Hamad, Yuan Lu, G. V. Levin, Ankit Saxena, Sanjeev Noel, Daniela Ostrowski, John F. Wilber, Sudipa Sarkar, Laurence S. Magder and Rizwan Ahmed and has published in prestigious journals such as Cell, Diabetes Care and Diabetes.

In The Last Decade

Thomas Donner

27 papers receiving 1.3k citations

Hit Papers

Insulin expression and C-peptide in type 1 diabetes subje... 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Donner United States 17 720 461 347 253 228 29 1.4k
René Valéro France 26 573 0.8× 535 1.2× 204 0.6× 549 2.2× 89 0.4× 94 1.9k
Laura M. Jacobsen United States 19 1.1k 1.5× 901 2.0× 974 2.8× 256 1.0× 182 0.8× 72 1.9k
Susan V. Hughes United Kingdom 21 635 0.9× 199 0.4× 219 0.6× 340 1.3× 172 0.8× 34 1.9k
Charles Buchanan United Kingdom 19 730 1.0× 276 0.6× 267 0.8× 417 1.6× 32 0.1× 53 1.5k
Silvia Ippolito Italy 22 440 0.6× 161 0.3× 90 0.3× 274 1.1× 96 0.4× 57 1.3k
Qi Yu China 20 345 0.5× 159 0.3× 293 0.8× 408 1.6× 132 0.6× 104 1.7k
Rodolfo Guardado‐Mendoza Mexico 19 348 0.5× 376 0.8× 181 0.5× 296 1.2× 51 0.2× 44 1.1k
M. Mochizuki Japan 19 226 0.3× 195 0.4× 236 0.7× 554 2.2× 244 1.1× 61 1.4k
Zhuo Liu China 23 209 0.3× 315 0.7× 99 0.3× 455 1.8× 97 0.4× 134 1.7k
Martin Press United Kingdom 19 585 0.8× 282 0.6× 287 0.8× 290 1.1× 43 0.2× 52 1.3k

Countries citing papers authored by Thomas Donner

Since Specialization
Citations

This map shows the geographic impact of Thomas Donner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Donner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Donner more than expected).

Fields of papers citing papers by Thomas Donner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Donner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Donner. The network helps show where Thomas Donner may publish in the future.

Co-authorship network of co-authors of Thomas Donner

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Donner. A scholar is included among the top collaborators of Thomas Donner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Donner. Thomas Donner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Shapiro, A. M. James, David Thompson, Thomas Donner, et al.. (2021). Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device. Cell Reports Medicine. 2(12). 100466–100466. 189 indexed citations breakdown →
3.
Ahmed, Rizwan, Zahra Omidian, Benjamin Cornwell, et al.. (2019). A Public BCR Present in a Unique Dual-Receptor-Expressing Lymphocyte from Type 1 Diabetes Patients Encodes a Potent T Cell Autoantigen. Cell. 177(6). 1583–1599.e16. 88 indexed citations
4.
Omidian, Zahra, et al.. (2018). IL-17 and limits of success. Cellular Immunology. 339. 33–40. 30 indexed citations
5.
Donner, Thomas, et al.. (2018). Improvements in A1C and Time-in-Range in DIY Closed-Loop (OpenAPS) Users. Diabetes. 67(Supplement_1). 39 indexed citations
6.
Saxena, Ankit, Hideo Yagita∥, Thomas Donner, & Abdel Rahim A. Hamad. (2017). Expansion of FasL-Expressing CD5+ B Cells in Type 1 Diabetes Patients. Frontiers in Immunology. 8. 402–402. 14 indexed citations
7.
Hamad, Abdel Rahim A., Rizwan Ahmed, Thomas Donner, & Georgia Fousteri. (2016). B cell-targeted immunotherapy for type 1 diabetes: What can make it work?. PubMed. 21(115). 213–9. 20 indexed citations
8.
Donner, Thomas & Joshua J. Joseph. (2015). Long-term insulin glargine therapy in type 2 diabetes mellitus: a focus on cardiovascular outcomes. Vascular Health and Risk Management. 11. 107–107. 15 indexed citations
9.
Saxena, Ankit, et al.. (2014). Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy. Cytokine. 74(1). 27–34. 242 indexed citations
10.
Shaya, Fadia T., Yan Xia, Pei‐Jung Lin, et al.. (2010). US Trends in Glycemic Control, Treatment, and Comorbidity Burden in Patients With Diabetes. Journal of Clinical Hypertension. 12(10). 826–832. 25 indexed citations
11.
Donner, Thomas, et al.. (2010). Dietary supplementation with d-tagatose in subjects with type 2 diabetes leads to weight loss and raises high-density lipoprotein cholesterol. Nutrition Research. 30(12). 801–806. 53 indexed citations
12.
Donner, Thomas, et al.. (2008). Diabetes Management in the Hospital. Medical Clinics of North America. 92(2). 407–425. 13 indexed citations
13.
Lu, Yuan, G. V. Levin, & Thomas Donner. (2007). Tagatose, a new antidiabetic and obesity control drug. Diabetes Obesity and Metabolism. 10(2). 109–134. 169 indexed citations
14.
Fernández-Egea, Emilio, Brian Miller, Miquel Bernardo, Thomas Donner, & Brian Kirkpatrick. (2007). Parental history of Type 2 diabetes in patients with nonaffective psychosis. Schizophrenia Research. 98(1-3). 302–306. 63 indexed citations
15.
Dixon, Lisa B., Julie Kreyenbuhl, Faith Dickerson, et al.. (2004). A Comparison of Type 2 Diabetes Outcomes Among Persons With and Without Severe Mental Illnesses. Psychiatric Services. 55(8). 892–900. 92 indexed citations
16.
Saudek, Christopher D., Richard R. Rubin, & Thomas Donner. (2001). The Johns Hopkins Guide to Diabetes: For Patients and Families. 1 indexed citations
17.
Ezzo, Jeanette, et al.. (2001). Is Massage Useful in the Management of Diabetes? A Systematic Review. Diabetes Spectrum. 14(4). 218–224. 24 indexed citations
18.
Donner, Thomas, John F. Wilber, & Daniela Ostrowski. (1999). D‐tagatose, a novel hexose: acute effects on carbohydrate tolerance in subjects with and without type 2 diabetes. Diabetes Obesity and Metabolism. 1(5). 285–291. 104 indexed citations
19.
Donner, Thomas, et al.. (1999). Effects of Acute and Repeated Oral Doses ofd-Tagatose on Plasma Uric Acid in Normal and Diabetic Humans. Regulatory Toxicology and Pharmacology. 29(2). S57–S65. 32 indexed citations
20.
Duckworth, William C., Christopher D. Saudek, Anita Giobbie‐Hurder, et al.. (1998). The Veterans Affairs Implantable Insulin Pump Study: Effect on cardiovascular risk factors. Diabetes Care. 21(10). 1596–1602. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026